Cimpress stock price target raised to $78 by Truist on strong outlook

Truist Securities raised its price target for Cimpress N.V. (NASDAQ:CMPR) to $78.00 from $74.00, maintaining a Buy rating, following management's analyst day which revealed Q1 2026 results tracking ahead of expectations and FY2028 guidance materially above consensus. This upgrade comes despite a recent Q4 2025 earnings report showing a significant EPS miss of -$1.02 against a forecasted $0.98, though revenue slightly beat estimates at $869.48 million. Truist remains constructive, citing momentum in new product categories and anticipated profitability improvements, while the stock has gained 39% over the past six months.

Analysis

Cimpress (CMPR) presents a mixed but forward-looking positive profile, underscored by a recent price target increase to $78.00 from Truist Securities, which maintains a Buy rating. The upgrade is primarily driven by management's optimistic analyst day, where it was revealed that fiscal Q1 2026 results are tracking ahead of schedule and long-term guidance for fiscal year 2028 is "materially above consensus." This bullish outlook is supported by perceived momentum in newer product categories, growing customer lifetime value, and strength in its U.S. Upload and Print business. However, this positive forward guidance is contrasted sharply by the company's most recent reported quarter (Q4 2025), which featured a significant earnings per share miss of -$1.02 against a forecast of $0.98, a negative surprise of over 200%. This was partially offset by a modest 2.99% revenue beat for the same period. Despite the earnings miss, the stock has demonstrated strong momentum, gaining 39% over the past six months, suggesting that investors are currently weighing the promising long-term guidance more heavily than the recent bottom-line underperformance.

Key Decisions for Investors

• Investors should weigh the company's highly optimistic long-term guidance and strong stock momentum against the significant risk highlighted by the recent -204.08% EPS miss.
• Monitor upcoming quarterly results closely for evidence that profitability is improving as guided, which would validate Truist's thesis on deleveraging and favorable capital allocation.
• Considering the stock's 39% run-up over six months, a hold or cautious accumulation strategy may be prudent until management demonstrates tangible progress toward its materially above-consensus fiscal 2028 targets.